UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers

Wiener Klinische Wochenschrift, 2021-04, Vol.133 (7-8), p.359-363

2021

Volltextzugriff (PDF)

Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysis

Annals of hematology, 2020-05, Vol.99 (5), p.1031-1040

2020

Volltextzugriff (PDF)

A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application Development

JMIR public health and surveillance, 2020-06, Vol.6 (2), p.e19033-e19033

2020

Volltextzugriff (PDF)

Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy

ESMO open, 2020-06, Vol.5 (3), p.e000810-e000810, Article e000810

2020

Volltextzugriff (PDF)

Bortezomib for the treatment of refractory Type‐1 cryoglobulinaemia

British journal of haematology, 2010-07, Vol.150 (2), p.235-237

2010

Volltextzugriff (PDF)

Routine Use of Pamidronate in NSCLC Patients with Bone Metastasis: Results from a Retrospective Analysis

Anticancer research, 2009-12, Vol.29 (12), p.5245-5250

2009

Volltextzugriff (PDF)

High levels of anti–SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine

European journal of cancer (1990), 2021-09, Vol.154, p.4-6

2021

Volltextzugriff (PDF)

Frequency of heterozygous Parkin mutations in healthy subjects: Need for careful prospective follow-up examination of mutation carriers

Parkinsonism & related disorders, 2009-07, Vol.15 (6), p.425-429

2009

Volltextzugriff (PDF)

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

Clinical cancer research, 2019-07, Vol.25 (13), p.3839-3846

2019

Volltextzugriff (PDF)

Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave

International journal of cancer, 2022-02, Vol.150 (3), p.431-439

2022

Volltextzugriff (PDF)

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron

Cancer cell, 2022-05, Vol.40 (5), p.444-446

2022

Volltextzugriff (PDF)

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study

European journal of cancer (1990), 2022-04, Vol.165, p.184-194

2022

Volltextzugriff (PDF)

Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations

JAMA oncology, 2022-01, Vol.8 (1), p.106

2022

Volltextzugriff (PDF)

Low Expression of Junctional Adhesion Molecule A Is Associated with Metastasis and Poor Survival in Pancreatic Cancer

Annals of surgical oncology, 2012-12, Vol.19 (13), p.4330-4336

2012

Volltextzugriff (PDF)

Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry

Acta haematologica, 2021-05, Vol.144 (3), p.259-263

2021

Volltextzugriff (PDF)

Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer

JAMA oncology, 2022-11, Vol.8 (11), p.1694

2022

Volltextzugriff (PDF)

Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort

ESMO open, 2023-06, Vol.8 (3), p.101559-101559, Article 101559

2023

Volltextzugriff (PDF)

“Real‐life” outcome of gastrointestinal tumor therapies: A single‐center comparative study

Cancer reports, 2019-10, Vol.2 (5), p.n/a

2019

Volltextzugriff (PDF)

Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial

Breast cancer research and treatment, 2015-01, Vol.149 (2), p.449-460

2015

Volltextzugriff (PDF)

Effect of gender on the outcome of patients receiving nivolumab for metastatic renal cancer: Results from a large study population

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16087-e16087

2019

Volltextzugriff (PDF)

Association of body mass index and systemic inflammation index with survival in patients with renal cell cancer treated with nivolumab

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16077-e16077

2019

Volltextzugriff (PDF)

Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma

British journal of haematology, 2003-08, Vol.122 (4), p.607-616

2003

Volltextzugriff (PDF)

Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study

Arteriosclerosis, thrombosis, and vascular biology, 2000-02, Vol.20 (2), p.529-537

2000

Volltextzugriff (PDF)

Procalcitonin‐reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients

British journal of haematology, 2001-10, Vol.115 (1), p.53-57

2001

Volltextzugriff (PDF)

A multi-functional mobile information system for hospital assistance

Proceedings of the 26th IEEE International Symposium on Computer-Based Medical Systems, 2013, p.365-368

2013

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

KollektionOxford University Press Journals Current

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(75)
Deutsch
(18)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers

Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysis

A Web- and App-Based Connected Care Solution for COVID-19 In- and Outpatient Care: Qualitative Study and Application Development

Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy

Bortezomib for the treatment of refractory Type‐1 cryoglobulinaemia

Routine Use of Pamidronate in NSCLC Patients with Bone Metastasis: Results from a Retrospective Analysis

High levels of anti–SARS-CoV-2 IgG antibodies in previously infected patients with cancer after a single dose of BNT 162b2 vaccine

Frequency of heterozygous Parkin mutations in healthy subjects: Need for careful prospective follow-up examination of mutation carriers

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave

Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron

Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study

Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations

Low Expression of Junctional Adhesion Molecule A Is Associated with Metastasis and Poor Survival in Pancreatic Cancer

Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry

Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer

Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort

“Real‐life” outcome of gastrointestinal tumor therapies: A single‐center comparative study

Effectiveness of an additional individualized multi-component complementary medicine treatment on health-related quality of life in breast cancer patients: a pragmatic randomized trial

Effect of gender on the outcome of patients receiving nivolumab for metastatic renal cancer: Results from a large study population

Association of body mass index and systemic inflammation index with survival in patients with renal cell cancer treated with nivolumab

Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma

Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study

Procalcitonin‐reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients

A multi-functional mobile information system for hospital assistance

Aktive Filter

Suchergebnisse filtern